Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1037389 NEW YORK, NY
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$13,813,443
+$2,045,828 QoQ
Shares Held
413,700
-26.3% QoQ
Ownership
0.420%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#47
of 311 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. RARE ranks #42 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in RARE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,813,443 413,700
2026-03-31 $11,767,615 561,700
2025-12-31 $8,420,300 366,100
2025-09-30 $658,752 21,900
2025-06-30 $7,573,788 208,300
2025-03-31 $10,848,516 299,600
2024-12-31 $10,715,229 254,700
2024-09-30 $10,115,655 182,100
2023-06-30 $904,148 19,600
2021-12-31 $3,985,866 47,400
2021-09-30 $6,457,604 71,600
2021-06-30 $44,089,840 462,400
2021-03-31 $16,486,928 144,800
2020-12-31 $13,123,164 94,800